
Quadrivio exits Pantex in trade sale
Italian alternative investment fund Quadrivio has made a gross IRR of 50% on the exit of Italy-based personal hygiene company Pantex, less than 24 months after its initial acquisition.
The exit marks the seventh realisation from Fondo Quadrivio Q2 and sees the GP fully exit its stake.
Quadrivio netted an estimated 2-3x return on capital and a gross IRR of more than 50% on the deal, 24 months after it invested in the business.
Since acquiring 99% of the business in 2015, Pantex's sales have increased by roughly 60% to around €70m, with 30% EBITDA growth, the GP said in a statement.
Previous funding
Quadrivio acquired a 99% stake in Pantex in 2015 via its Quadrivio Q2 fund.
Company
Pantex is headquartered in Sulmona, Aquila. The group makes plastic and elastic components for personal hygiene products and has manufacturing plants in Italy, UAE and the US.
Pantex's main clients are both branded and private label personal care companies.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater